Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02708290 |
Recruitment Status :
Completed
First Posted : March 15, 2016
Results First Posted : December 20, 2019
Last Update Posted : November 27, 2020
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Observational |
---|---|
Study Design | Observational Model: Cohort; Time Perspective: Prospective |
Conditions |
Autistic Disorder Autism ASD |
Intervention |
Other: MITA Prefrontal Synthesis exercises - each activity adapts to deliver the exercise that is at the exact level of difficulty appropriate for a child at any given point in time |
Enrollment | 6454 |
Recruitment Details | |
Pre-assignment Details |
MITA was made available gratis at all app stores from 2015 to 2020. From this pool of potential study participants, we selected participants for the observation clinical study based on the following criteria:
This resulted in 6454 participants, from whom we have selected the test and control groups |
Arm/Group Title | Test Arm: Completed More Than One Thousand Exercises | Control Arm: the Rest of Participants |
---|---|---|
![]() |
The test group (assigned at the end of the three-year study) included participants who demonstrated engagement with the intervention by completing more than one thousand MITA exercises and making no more than one error per exercise. MITA imagination exercises - each activity adapts to deliver the exercise that is at the exact level of difficulty appropriate for a child at any given point in time: Mental Imagery Therapy for Autism (MITA) is an early-intervention application for children with Autism Spectrum Disorder (ASD). MITA app uses adaptive-learning technologies, with fun, educational exercises that adapt to a child's abilities, resulting in a highly-customized learning experience. The MITA application is available for free in the Apple Store, Google Play, and Amazon App Store. |
The control group (assigned at the end of the three-year study) included the participants matched by age, gender, expressive language, receptive language, sociability, cognitive awareness, and health score at the 1st evaluation to the test group participants. The participants that were not matched to the test group were not included into the comparison between the groups. |
Period Title: Overall Study | ||
Started | 1009 | 1009 |
Completed | 1009 | 1009 |
Not Completed | 0 | 0 |
Arm/Group Title | Test Arm | Control Arm | Total | |
---|---|---|---|---|
![]() |
The test group included participants who completed more than one thousand MITA exercises and made no more than one error per exercise. MITA imagination exercises - each activity adapts to deliver the exercise that is at the exact level of difficulty appropriate for a child at any given point in time: Mental Imagery Therapy for Autism (MITA) is an early-intervention application for children with Autism Spectrum Disorder (ASD). MITA app uses adaptive-learning technologies, with fun, educational exercises that adapt to a child's abilities, resulting in a highly-customized learning experience. The MITA application is available for free in the Apple Store, Google Play, and Amazon App Store. |
The control group included the rest of participants. The test group participants were matched to the control group by age, gender, expressive language, receptive language, sociability, cognitive awareness, and health at the 1st evaluation. | Total of all reporting groups | |
Overall Number of Baseline Participants | 1009 | 1009 | 2018 | |
![]() |
[Not Specified]
|
|||
Age, Customized
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 1009 participants | 1009 participants | 2018 participants | |
1009 100.0%
|
1009 100.0%
|
2018 100.0%
|
||
Sex: Female, Male
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 1009 participants | 1009 participants | 2018 participants | |
Female |
262 26.0%
|
252 25.0%
|
514 25.5%
|
|
Male |
747 74.0%
|
757 75.0%
|
1504 74.5%
|
|
Race and Ethnicity Not Collected
[1] Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 0 participants | 0 participants | 0 participants | |
0 | ||||
[1]
Measure Analysis Population Description: Race and Ethnicity were not collected from any participant.
|
Name/Title: | Dr. Andrey Vyshedskiy, Founder |
Organization: | ImagiRation LLC |
Phone: | 6174338577 |
EMail: | vysha@bu.edu |
Responsible Party: | ImagiRation, LLC |
ClinicalTrials.gov Identifier: | NCT02708290 |
Other Study ID Numbers: |
MITA001 |
First Submitted: | March 1, 2016 |
First Posted: | March 15, 2016 |
Results First Submitted: | September 30, 2019 |
Results First Posted: | December 20, 2019 |
Last Update Posted: | November 27, 2020 |